Skip to main content
. 2020 Jun 9;196(11):1018–1033. doi: 10.1007/s00066-020-01637-5

Fig. 5.

Fig. 5

Immunophenotyping of whole blood of the prostate adenocarcinoma patients treated with IMRT (a) and SABR (b). Whole blood was collected before the start of the treatment and after the last radiation fraction. Expression values were interpolated for IMRT patients for radiation dose of 36.25 Gy for better comparison with SABR-related values. The counts of B cells, T cells, neutrophils, natural killer (NK) cells, monocytes, and myeloid-derived suppressor cells (MDSCs) per ml of peripheral blood are displayed as well as the percentages of HLA-DR-expressing monocytes (Mo) and programmed death 1 receptor-expressingT helper cells (TH.PD1). Hash indicates comparisons showing at least a large effect size (|rW| ≥ 0.5)